Kym; Philip R.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Kym; Philip R..The latest application filed is for "methods of treating parkinson's disease".
Company Profile
29.63.78
- Kym; Philip R. - Libertyville IL
- Kym; Philip R - Libertyville IL
- Kym; Philip R. - Grayslake IL
- Kym, Philip R - Grayslake IL
Patent Activity
| Patent | Date |
|---|---|
| Methods Of Treating Parkinson's Disease App 20220153765 - Cardinal-David; Benoit ; et al. | 2022-05-19 |
| Methods of treating Parkinson's disease Grant 11,091,507 - Enright , et al. August 17, 2 | 2021-08-17 |
| Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use App 20210238159 - Altenbach; Robert J. ; et al. | 2021-08-05 |
| Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use Grant 10,988,454 - Altenbach , et al. April 27, 2 | 2021-04-27 |
| Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use Grant 10,981,890 - Altenbach , et al. April 20, 2 | 2021-04-20 |
| Protein tyrosine phosphatase inhibitors and methods of use thereof Grant 10,954,202 - Xiong , et al. March 23, 2 | 2021-03-23 |
| Protein Tyrosine Phosphatase Inhibitors And Methods Of Use Thereof App 20210009542 - Xiong; Zhaoming ; et al. | 2021-01-14 |
| Protein tyrosine phosphatase inhibitors and methods of use thereof Grant 10,851,073 - Halvorsen , et al. December 1, 2 | 2020-12-01 |
| Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use Grant 10,844,041 - Altenbach , et al. November 24, 2 | 2020-11-24 |
| Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use Grant 10,844,042 - Altenbach , et al. November 24, 2 | 2020-11-24 |
| Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use Grant 10,829,473 - Altenbach , et al. November 10, 2 | 2020-11-10 |
| Protein Tyrosine Phosphatase Inhibitors And Methods Of Use Thereof App 20200299246 - Halvorsen; Geoff T. ; et al. | 2020-09-24 |
| Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use App 20200277273 - Altenbach; Robert J. ; et al. | 2020-09-03 |
| Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use App 20200277274 - Altenbach; Robert J. ; et al. | 2020-09-03 |
| Modulators Of The Cystic Fibrosis Transmembrane Conductance Regulator Protein And Methods Of Use App 20200277275 - Altenbach; Robert J. ; et al. | 2020-09-03 |
| Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use App 20200277276 - Altenbach; Robert J. ; et al. | 2020-09-03 |
| Carbidopa Prodrugs App 20200262852 - Cardinal-David; Benoit ; et al. | 2020-08-20 |
| Carbidopa prodrug Grant 10,730,895 - Kym , et al. | 2020-08-04 |
| N-sulfonylated-pyrazolo[3,4-b]pyridin-6-carboxamides and method of use Grant 10,647,717 - Akkari , et al. | 2020-05-12 |
| Deuterated Cftr Modulators And Methods Of Use App 20200123137 - Chan; Vincent S. ; et al. | 2020-04-23 |
| Heteroaryl substituted pyridines and methods of use Grant 10,604,515 - Altenbach , et al. | 2020-03-31 |
| Carbidopa Prodrug App 20190375770 - Cardinal-David; Benoit ; et al. | 2019-12-12 |
| N-Sulfonylated-Pyrazolo[3,4-b]Pyridin-6-Carboxamides and Method of Use App 20190330207 - Akkari; Rhalid ; et al. | 2019-10-31 |
| Substituted Pyrrolidines and Methods of Use App 20190315687 - Altenbach; Robert J. ; et al. | 2019-10-17 |
| Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use Grant 10,428,017 - Altenbach , et al. October 1, 2 | 2019-10-01 |
| Substituted pyrrolidines and methods of use Grant 10,399,940 - Altenbach , et al. Sep | 2019-09-03 |
| Carbidopa and L-Dopa Prodrugs and Methods of Use App 20190224220 - Kym; Philip R. ; et al. | 2019-07-25 |
| N-SULFONYLATED PYRAZOLO[3,4-b]PYRIDIN-6-CARBOXAMIDES AND METHOD OF USE App 20190202823 - Akkari; Rhalid ; et al. | 2019-07-04 |
| Substituted Tricyclics and Method of Use App 20190135827 - Altenbach; Robert J. ; et al. | 2019-05-09 |
| Substituted Chromanes and Method of Use App 20190127356 - Altenbach; Robert J. ; et al. | 2019-05-02 |
| N-sulfonylated pyrazolo[3,4-b]pyridin-6-carboxamides and method of use Grant 10,259,810 - Akkari , et al. | 2019-04-16 |
| Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use App 20190077784 - Altenbach; Robert J. ; et al. | 2019-03-14 |
| Heteroaryl Substituted Pyridines and Methods of Use App 20190055229 - Altenbach; Robert J. ; et al. | 2019-02-21 |
| Carbidopa and L-dopa prodrugs and methods of use Grant 10,174,061 - Cardinal-David , et al. J | 2019-01-08 |
| Heteroaryl substituted pyridines and methods of use Grant 10,138,227 - Altenbach , et al. Nov | 2018-11-27 |
| Modulators of cystic fibrosis transmembrane conductance regulator protein Grant 10,118,916 - Altenbach , et al. November 6, 2 | 2018-11-06 |
| Trpv3 Modulators App 20180243298 - Black; Lawrence ; et al. | 2018-08-30 |
| Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use App 20180244611 - Altenbach; Robert J. ; et al. | 2018-08-30 |
| Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use App 20180244640 - Altenbach; Robert J. ; et al. | 2018-08-30 |
| Substituted pyrrolidines and methods of use Grant 9,981,910 - Altenbach , et al. May 29, 2 | 2018-05-29 |
| N-SULFONYLATED PYRAZOLO[3,4-b]PYRIDIN-6-CARBOXAMIDES AND METHOD OF USE App 20180105522 - Akkari; Rhalid ; et al. | 2018-04-19 |
| Substituted Pyrrolidines and Methods of Use App 20180099931 - Altenbach; Robert J. ; et al. | 2018-04-12 |
| Substituted Pyrrolidines and Methods of Use App 20180099932 - Altenbach; Robert J. ; et al. | 2018-04-12 |
| Carbidopa and L-Dopa Prodrugs and Methods of use App 20180079762 - Cardinal-David; Benoit ; et al. | 2018-03-22 |
| N-sulfonylated pyrazolo[3,4-b]pyridin-6-carboxamides and method of use Grant 9,890,158 - Akkari , et al. February 13, 2 | 2018-02-13 |
| Substituted Tricyclics and Method of Use App 20180037587 - Altenbach; Robert J. ; et al. | 2018-02-08 |
| Substituted tricyclics and method of use Grant 9,840,513 - Altenbach , et al. December 12, 2 | 2017-12-12 |
| Heteroaryl Substituted Pyridines And Methods Of Use App 20170349576 - Altenbach; Robert J. ; et al. | 2017-12-07 |
| Modulators Of Cystic Fibrosis Transmembrane Conductance Regulator Protein App 20170305891 - Altenbach; Robert J. ; et al. | 2017-10-26 |
| Substituted pyrazolo[3,4-b]pyridin-6-carboxylic acids and method of use Grant 9,796,711 - Akkari , et al. October 24, 2 | 2017-10-24 |
| Substituted Chromanes And Method Of Use App 20170190693 - Altenbach; Robert J. ; et al. | 2017-07-06 |
| Substituted chromanes and method of use Grant 9,642,831 - Altenbach , et al. May 9, 2 | 2017-05-09 |
| Novel Compounds For Treatment Of Cystic Fibrosis App 20170100386 - Akkari; Rhalid ; et al. | 2017-04-13 |
| N-SULFONYLATED PYRAZOLO[3,4-b]PYRIDIN-6-CARBOXAMIDES AND METHOD OF USE App 20170101405 - Akkari; Rhalid ; et al. | 2017-04-13 |
| SUBSTITUTED PYRAZOLO[3,4-b]PYRIDIN-6-CARBOXYLIC ACIDS AND METHOD OF USE App 20170101406 - Akkari; Rhalid ; et al. | 2017-04-13 |
| Substituted tetrahydropyrans and method of use Grant 9,567,322 - Kym , et al. February 14, 2 | 2017-02-14 |
| Substituted Tricyclics And Method Of Use App 20170015675 - Altenbach; Robert J. ; et al. | 2017-01-19 |
| Carbidopa And L-Dopa Prodrugs And Methods Of Use App 20160362431 - CARDINAL-DAVID; Benoit ; et al. | 2016-12-15 |
| Carbidopa and L-dopa prodrugs and methods of use Grant 9,446,059 - Cardinal-David , et al. September 20, 2 | 2016-09-20 |
| Substituted Tetrahydropyrans And Method Of Use App 20160122331 - Kym; Philip R. ; et al. | 2016-05-05 |
| Substituted Chromanes And Method Of Use App 20160120841 - Kym; Philip R. ; et al. | 2016-05-05 |
| Carbidopa and L-Dopa Prodrugs and Methods of Use App 20160106765 - CARDINAL-DAVID; Benoit ; et al. | 2016-04-21 |
| TRPV3 modulators Grant 9,156,788 - Bayburt , et al. October 13, 2 | 2015-10-13 |
| TRPV3 modulators Grant 9,012,651 - Clapham , et al. April 21, 2 | 2015-04-21 |
| TRPV1 antagonists Grant 8,969,325 - Dart , et al. March 3, 2 | 2015-03-03 |
| Inhibitors of diacylglycerol O-acyltransferase type 1 enzyme Grant 8,901,152 - Judd , et al. December 2, 2 | 2014-12-02 |
| TRPV1 antagonists Grant 8,859,584 - Woller , et al. October 14, 2 | 2014-10-14 |
| TRPV1 antagonists Grant 8,802,711 - Gomtsyan , et al. August 12, 2 | 2014-08-12 |
| TRPV1 antagonists Grant 8,796,328 - Gomtsyan , et al. August 5, 2 | 2014-08-05 |
| TRPV3 modulators Grant 8,772,499 - Bayburt , et al. July 8, 2 | 2014-07-08 |
| TRPV3 modulators Grant 8,772,500 - Bayburt , et al. July 8, 2 | 2014-07-08 |
| Novel Trpv3 Modulators App 20140080803 - Bayburt; Erol K. ; et al. | 2014-03-20 |
| Trpv1 Antagonists App 20130345255 - Gomtsyan; Arthur ; et al. | 2013-12-26 |
| TRPV1 antagonists Grant 8,609,692 - Gomtsyan , et al. December 17, 2 | 2013-12-17 |
| TRPV1 antagonists Grant 8,604,053 - Gomtsyan , et al. December 10, 2 | 2013-12-10 |
| Inhibitors of diacylglycerol O-acyltransferase type 1 enzyme Grant 8,586,594 - Souers , et al. November 19, 2 | 2013-11-19 |
| Inhibitors of diacylglycerol O-acyltransferase type 1 enzyme Grant 8,557,828 - Liu , et al. October 15, 2 | 2013-10-15 |
| Trpv1 Antagonists App 20130172334 - Dart; Michael J. ; et al. | 2013-07-04 |
| TRPV1 Antagonists App 20130158067 - Woller; Kevin R. ; et al. | 2013-06-20 |
| Novel Trpv3 Modulators App 20130150409 - Bayburt; Erol K. ; et al. | 2013-06-13 |
| Novel Trpv3 Modulators App 20130131036 - Bayburt; Erol K. ; et al. | 2013-05-23 |
| Inhibitors Of Diacylglycerol O-acyltransferase Type 1 Enzyme App 20120277223 - Judd; Andrew S. ; et al. | 2012-11-01 |
| TRPV3 Modulators App 20120245124 - Clapham; Bruce ; et al. | 2012-09-27 |
| TRPV1 Antagonists App 20120245163 - Gomtsyan; Arthur ; et al. | 2012-09-27 |
| Inhibitors Of Diacylglycerol O-acyltransferase Type 1 Enzyme App 20120238581 - Souers; Andrew J. ; et al. | 2012-09-20 |
| Inhibitors of diacylglycerol O-acyltransferase type 1 enzyme Grant 8,242,139 - Judd , et al. August 14, 2 | 2012-08-14 |
| Inhibitors of diacylglycerol O-acyltransferase type 1 enzyme Grant 8,202,878 - Souers , et al. June 19, 2 | 2012-06-19 |
| Inhibitors Of Diacylglycerol O-acyltransferase Type 1 Enzyme App 20120041003 - Liu; Gang ; et al. | 2012-02-16 |
| Inhibitors of diacylglycerol O-acyltransferase type 1 enzyme Grant 8,076,344 - Liu , et al. December 13, 2 | 2011-12-13 |
| Amide Derivatives As Trpv1 Antagonists App 20110288129 - Vasudevan; Anil ; et al. | 2011-11-24 |
| Amide derivatives as TRPV1 antagonists Grant 7,998,982 - Vasudevan , et al. August 16, 2 | 2011-08-16 |
| TRPV1 antagonists Grant 7,998,993 - Perner , et al. August 16, 2 | 2011-08-16 |
| Repeated Dosing of TRPV1 Antagonists App 20100210682 - Faltynek; Connie R. ; et al. | 2010-08-19 |
| Trpv1 Antagonists App 20100137360 - Gomtsyan; Arthur R. ; et al. | 2010-06-03 |
| Trpv1 Antagonists App 20100120846 - Gomtsyan; Arthur R. ; et al. | 2010-05-13 |
| Trpv1 Antagonists App 20090124666 - Perner; Richard J. ; et al. | 2009-05-14 |
| Glucocorticoid receptor ligands for the treatment of metabolic disorders Grant 7,521,439 - Bishop , et al. April 21, 2 | 2009-04-21 |
| Amide Derivatives As Trpv1 Antagonists App 20090062345 - Vasudevan; Anil ; et al. | 2009-03-05 |
| Inhibitors of Diacylglycerol O-acyltransferase Type 1 Enzyme App 20080312282 - Judd; Andrew S. ; et al. | 2008-12-18 |
| Inhibitors of Diacylglycerol O-acyltransferase Type 1 Enzyme App 20080293713 - Liu; Gang ; et al. | 2008-11-27 |
| Inhibitors Of Diacylglycerol O-acyltransferase Type 1 Enzyme App 20080182861 - Souers; Andrew J. ; et al. | 2008-07-31 |
| Inhibitors of diacylglycerol O-acyltransferase type 1 enzyme App 20080064717 - Iyengar; Rajesh ; et al. | 2008-03-13 |
| Inhibitors of diacylglycerol O-acyltransferase type 1 enzyme App 20080015227 - Kym; Philip R. ; et al. | 2008-01-17 |
| Compounds active at the glucocorticoid receptor II Grant 7,220,752 - Pelcman , et al. May 22, 2 | 2007-05-22 |
| Novel glucocorticoid receptor ligands for the treatment of metabolic disorders App 20070027117 - Bishop; Richard D. ; et al. | 2007-02-01 |
| Thienopyridones as AMPK activators for the treatment of diabetes and obesity App 20060287356 - Iyengar; Rajesh R. ; et al. | 2006-12-21 |
| Glucocorticoid receptor ligands for the treatment of metabolic disorders Grant 7,141,559 - Bishop , et al. November 28, 2 | 2006-11-28 |
| Thienopyridones as AMPK activators for the treatment of diabetes and obesity Grant 7,119,205 - Iyengar , et al. October 10, 2 | 2006-10-10 |
| Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor Grant 7,071,182 - Souers , et al. July 4, 2 | 2006-07-04 |
| Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor Grant 7,049,307 - Souers , et al. May 23, 2 | 2006-05-23 |
| 2-Aminoquinolines as melanin concentrating hormone receptor antagonists Grant 6,989,392 - Collins , et al. January 24, 2 | 2006-01-24 |
| Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor App 20050277638 - Souers, Andrew J. ; et al. | 2005-12-15 |
| Glucocorticoid-selective anti-inflammatory agents Grant 6,951,942 - Coghlan , et al. October 4, 2 | 2005-10-04 |
| Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor App 20050209274 - Lynch, John K. ; et al. | 2005-09-22 |
| Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor App 20050187279 - Souers, Andrew J. ; et al. | 2005-08-25 |
| Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor App 20050187387 - Lynch, John K. ; et al. | 2005-08-25 |
| Antagonists of melanin concentrating hormone receptor Grant 6,921,821 - Blackburn , et al. July 26, 2 | 2005-07-26 |
| Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor App 20050137187 - Souers, Andrew J. ; et al. | 2005-06-23 |
| Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor App 20050137243 - Souers, Andrew J. ; et al. | 2005-06-23 |
| Thienopyridones as AMPK activators for the treatment of diabetes and obesity App 20050038068 - Iyengar, Rajesh R. ; et al. | 2005-02-17 |
| Novel glucocorticoid receptor ligands for the treatment of metabolic disorders App 20040235810 - Bishop, Richard D. ; et al. | 2004-11-25 |
| Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor Grant 6,818,772 - Kym , et al. November 16, 2 | 2004-11-16 |
| Antagonists of melanin concentrating hormone receptor App 20040106645 - Blackburn, Christopher ; et al. | 2004-06-03 |
| 2-Aminoquinolines as melanin concentrating hormone receptor antagonists App 20040063756 - Collins, Christine A. ; et al. | 2004-04-01 |
| Compounds active at the glucocorticoid receptor II App 20040063781 - Pelcman, Benjamin ; et al. | 2004-04-01 |
| Antagonists of melanin concentrating hormone effects on the melanin concetrating hormone receptor App 20030229119 - Kym, Philip R. ; et al. | 2003-12-11 |
| Potassium channel openers Grant 6,645,968 - Altenbach , et al. November 11, 2 | 2003-11-11 |
| Compounds active at the glucocorticoid receptor App 20030166725 - Apelgvist, Theresa ; et al. | 2003-09-04 |
| Glucocortiocoid-selective antinflammatory agents App 20030073703 - Coghlan, Michael J. ; et al. | 2003-04-17 |
| Glucocortiocoid-selective antinflammatory agents Grant 6,506,766 - Coghlan , et al. January 14, 2 | 2003-01-14 |
| Glucocorticoid receptor antagonists for treatment of diabetes Grant 6,436,986 - Kym , et al. August 20, 2 | 2002-08-20 |
| Potassium channel openers App 20020028836 - Altenbach, Robert J. ; et al. | 2002-03-07 |
| Glucocorticoid receptor antagonists for treatment of diabetes Grant 6,329,534 - Kym , et al. December 11, 2 | 2001-12-11 |
| Glucocorticoid receptor antagonists for treatment of diabetes App 20010041802 - Kym, Philip R. ; et al. | 2001-11-15 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 